• 3P Innovation and Mikron Automation partner to offer DPI manufacturing systems

  3P innovation, which makes filling systems for dry powder inhaler blisters, and Mikron Automation, which offers device assembly systems, announced that they have partnered to provide integrated manufacturing systems for blister-based DPIs. The companies say that… [Read more . . .]

• Insilico Medicine gets clearance for Phase 1 trial of rentosertib (ISM001-055) inhalation solution

  Insilico Medicine, which has facilities in the US and China, said that an IND for a Phase 1 PK trial of rentosertib (ISM001-055) inhalation solution has been cleared by the CDE. The company said that… [Read more . . .]

• Transpire Bio opens R&D facility in China

  US-based Transpire Bio announced that it has opened an R&D facility in Shanghai, China with approximately 40 employees who will work on development of generic OINDPs for the UK, European, and Asian Pacific markets. Transpire… [Read more . . .]

• FDA approves AstraZeneca’s Breztri Aerosphere budesonide / glycopyrrolate / formoterol MDI for the treatment of asthma

  AstraZeneca announced that the FDA has approved the company’s Breztri Aerosphere budesonide / glycopyrrolate / formoterol MDI for the treatment of asthma in patients aged 12 and older. The agency originally approved Breztri for the treatment of… [Read more . . .]

• Avalyn Pharma announces appointments of Adam Golden as Head of Business Development and Frank Salisbury as Senior VP, Commercial

  Inhaled drug developer Avalyn Pharma has announced the appointments of attorney Adam Golden as General Counsel and Head of Business Development and pharma sales and marketing veteran Frank Salisbury as Senior VP, Commercial. Golden was… [Read more . . .]

• FDA approves Cipla’s generic of Ventolin HFA albuterol MDI

• Rocket Science Health gets additional US patent covering its nasal delivery technology

• Vistagen gets go-ahead for Phase 2 trial of refisolone (PH-80) nasal spray for the treatment of hot flashes

• FDA extends review of Savara’s BLA for Molbreevi molgramostim inhalation solution for the treatment of aPAP

• ARS Pharma and ALK announce that Health Canada has approved neffy epinephrine nasal spray

More news . . .